Pharmacology

Hormone Therapy and Incontinence in Younger Postmenopausal Women

Results from large, randomized clinical trials have indicated that postmenopausal women aged 60 years and older who use hormone therapy (HT) have a higher risk of urinary incontinence (UI) compared with similarly aged women who don’t use HT after menopause. Whether UI is associated with HT in younger postmenopausal women, however, is unknown. Researchers from Brigham and Women’s Hospital, Harvard Medical School, and Harvard School of Public Health, all in Boston, MA, and University of Pittsburgh, Pittsburgh, PA prospectively analyzed the association between incident UI and HT use in postmenopausal women aged 37 to 54 years between 2001 and 2003.


 

Recommended Reading

Sex and the Heart Failure Patient
Federal Practitioner
The Economics of High Dose Statin Therapy
Federal Practitioner
Higher Risk of Venous Thromboembolism with Bevacizumab
Federal Practitioner
What Should We Do About Proteinuria?
Federal Practitioner
Apraclonidine for the Diagnosis of Horner Syndrome
Federal Practitioner
Supporting Patients and Families Affected by Serious Mental Illness: The VA–National Alliance on Mental Illness Collaboration
Federal Practitioner
Eliminating Ethnic and Racial Disparities in Health Care
Federal Practitioner
Antibiotic Treatment of Acute Pyelonephritis
Federal Practitioner
Statins and Pneumonia
Federal Practitioner
Timing Parecoxib Administration with Colorectal Surgery
Federal Practitioner